Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Más filtros

Bases de datos
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
BMJ Open Ophthalmol ; 8(Suppl 3): A3, 2023 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-37797989

RESUMEN

A 12-year-old boy presented with 5 day history of blurry vision, 'wobbly eyes', tinnitus and difficulty seeing at night. Local ophthalmology noted bilateral optic disc swelling and referred him urgently for neurological investigations.Clinical Findings: At presentation VA was RE 0.00 and LE 0.2 with normal Ishihara colour vision. His extraocular movements were full without manifest strabismus. Fundoscopy showed bilateral optic disc swelling. Electrophysiology unexpectedly revealed a functionally cone isolated retina with markedly abnormal rod function. Pattern VEPs indicated bilateral macular pathway dysfunction affecting left eye more than right eye. Wide field imaging showed bilateral diffusely scattered yellow-white flecks in the midperiphery of each eye. His kinetic visual fields were moderately restricted bilaterally. MRI showed a Chiari 1 malformation with cerebellar tonsil herniation, but LP opening pressure was normal.Differential diagnosis included RDH5 retinopathy or vitamin A deficiency. On questioning he reported a diet restricted to only meat and biscuits. His vitamin A levels were subnormal at 0.14 umol/L (reference range 0.9-2.5umol/l) and he was started on high-dose Vitamin A supplements.Four months after supplementation retinal appearances had normalised, the rod ERGs recovered, nyctalopia and visual field restriction resolved. PVEPs had improved but an element of LE macular pathway dysfunction remained. Optic disc swelling settled leaving mild temporal pallor, particularly of the LE with some RNFL loss.It is important to recognise nutritional Vitamin A deficiency in children as prompt recognition and treatment can improve symptoms, reverse retinal pathology which we have demonstrated with electrophysiological findings.


Asunto(s)
Disco Óptico , Papiledema , Enfermedades de la Retina , Deficiencia de Vitamina A , Humanos , Masculino , Niño , Disco Óptico/patología , Vitamina A , Deficiencia de Vitamina A/patología , Retina/patología , Enfermedades de la Retina/patología , Papiledema/patología , Trastornos de la Visión/diagnóstico
2.
J Pharmacol Toxicol Methods ; 29(3): 129-38, 1993 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-8103377

RESUMEN

The elevated X-maze has strong claims to validity as an animal model of anxiety, both in theoretical basis and drug responses. The model is sensitive to actual and putative anxiolytics, but because insufficient time has elapsed since its discovery, no agent first predicted to be anxiolytic in the elevated X-maze has been brought into general use yet. It has an advantage in detecting anxiolytic and anxiogenic agents under the same operating conditions. The design and execution of experiments with the model is discussed and it is shown that baseline arm preference and the size or direction of drug effects differ in the procedural factors affecting them. Because it presents features of both passive and active avoidance and approach/avoidance conflict, it may prove able to detect drug effects in different forms of human anxiety and aid in understanding their neurobiology.


Asunto(s)
Ansiolíticos/farmacología , Ansiedad/tratamiento farmacológico , Animales , Ansiedad/inducido químicamente , Ansiedad/etiología , Conducta Animal/efectos de los fármacos , Modelos Animales de Enfermedad , Evaluación Preclínica de Medicamentos/métodos , Ratas
4.
J Physiol ; 223(3): 619-31, 1972 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-5045735

RESUMEN

1. At an ambient temperature of 20 degrees C, intraventricular injection of noradrenaline in the mouse resulted in hypothermia accompanied by a fall in metabolic rate and by cutaneous vasodilatation. Subcutaneous injection of noradrenaline resulted in hyperthermia with raised metabolic rate and cutaneous vasodilatation.2. The hypothermia and fall in oxygen consumption rate following intraventricular noradrenaline were prevented by pre-treatment with subcutaneous propranolol, while the cutaneous vasodilatation was un-affected. However, the effects of subcutaneously injected noradrenaline were completely abolished by subcutaneous propranolol. Intraventricular propranolol did not modify the hypothermic effect of intraventricular noradrenaline.3. The direction of the effect on body temperature of intraventricular noradrenaline was dependent upon ambient temperature; hypothermia occurring at low (15 degrees C) and hyperthermia at high (36 degrees C) ambient temperatures. However, when the possibility of any peripheral action of noradrenaline escaping into the systemic circulation was prevented by prior subcutaneous injection of propranolol, significant hypothermia could be detected at temperatures as high as 32 degrees C.4. The possibility that the effects of intraventricular noradrenaline could be due to complete abolition of central temperature regulation was further excluded by the occurrence of thermal salivation in all animals during experiments performed at 36 degrees C.5. It is suggested that, in the mouse, the hypothermic actions of intraventricular noradrenaline are due to a central effect, while its hyperthermic effects at high ambient temperature are due to escape of noradrenaline into the peripheral circulation. The hypothermia could be the result of selective activation of central heat loss mechanisms.6. Intraventricular noradrenaline was without effect on brain plasma-space although exposure to 100% oxygen caused a detectable fall.


Asunto(s)
Temperatura Corporal/efectos de los fármacos , Norepinefrina/administración & dosificación , Animales , Metabolismo Basal/efectos de los fármacos , Regulación de la Temperatura Corporal/efectos de los fármacos , Encéfalo/efectos de los fármacos , Ventrículos Cerebrales , Hipotálamo , Inyecciones , Inyecciones Subcutáneas , Masculino , Ratones , Norepinefrina/antagonistas & inhibidores , Norepinefrina/farmacología , Consumo de Oxígeno/efectos de los fármacos , Volumen Plasmático/efectos de los fármacos , Propranolol/farmacología , Piel/irrigación sanguínea , Temperatura Cutánea , Temperatura
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA